NanJing Pharmaceutical Company Limited (600713.SS)
CNY 4.86
(-0.21%)
CNY 4.86
(-0.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.49 Billion CNY | 13.04% |
| 2022 | 1.32 Billion CNY | 6.98% |
| 2021 | 1.23 Billion CNY | 18.96% |
| 2020 | 1.03 Billion CNY | -2.95% |
| 2019 | 1.06 Billion CNY | 122.78% |
| 2018 | 479.73 Million CNY | 4.08% |
| 2017 | 460.9 Million CNY | 32.88% |
| 2016 | 346.84 Million CNY | 33.92% |
| 2015 | 258.99 Million CNY | 43.5% |
| 2014 | 180.48 Million CNY | 67.9% |
| 2013 | 107.49 Million CNY | 368.19% |
| 2012 | -40.08 Million CNY | 75.29% |
| 2011 | -162.2 Million CNY | -1276.77% |
| 2010 | -11.78 Million CNY | -119.82% |
| 2009 | 59.45 Million CNY | 14.73% |
| 2008 | 51.82 Million CNY | -46.21% |
| 2007 | 96.34 Million CNY | 413.17% |
| 2006 | 18.77 Million CNY | -36.51% |
| 2005 | 29.57 Million CNY | 75.49% |
| 2004 | 16.85 Million CNY | -65.31% |
| 2003 | 48.56 Million CNY | 2.47% |
| 2002 | 47.39 Million CNY | -15.22% |
| 2001 | 55.9 Million CNY | -17.42% |
| 2000 | 67.69 Million CNY | -25.54% |
| 1999 | 90.91 Million CNY | 24.23% |
| 1998 | 73.18 Million CNY | 60.43% |
| 1997 | 45.61 Million CNY | 41.58% |
| 1996 | 32.22 Million CNY | 20.58% |
| 1995 | 26.72 Million CNY | 25.7% |
| 1994 | 21.25 Million CNY | 84.04% |
| 1993 | 11.55 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 384.96 Million CNY | 2.41% |
| 2024 Q2 | 281.98 Million CNY | -26.75% |
| 2024 Q3 | 348.6 Million CNY | -19.82% |
| 2023 Q2 | 283.23 Million CNY | 12.34% |
| 2023 Q4 | 375.89 Million CNY | 71.39% |
| 2023 FY | 1.49 Billion CNY | 13.04% |
| 2023 Q1 | 252.13 Million CNY | 9.57% |
| 2023 Q3 | 219.32 Million CNY | -22.57% |
| 2022 Q1 | 212.66 Million CNY | -16.98% |
| 2022 Q2 | 352.55 Million CNY | 65.78% |
| 2022 Q3 | 227.2 Million CNY | -35.56% |
| 2022 Q4 | 230.12 Million CNY | 1.29% |
| 2022 FY | 1.32 Billion CNY | 6.98% |
| 2021 Q1 | 162.1 Million CNY | -8.57% |
| 2021 FY | 1.23 Billion CNY | 18.96% |
| 2021 Q2 | 217.35 Million CNY | 34.08% |
| 2021 Q3 | 210.1 Million CNY | -3.34% |
| 2021 Q4 | 256.14 Million CNY | 21.91% |
| 2020 Q4 | 177.3 Million CNY | -6.8% |
| 2020 FY | 1.03 Billion CNY | -2.95% |
| 2020 Q1 | 128.7 Million CNY | 22.33% |
| 2020 Q2 | 180.01 Million CNY | 39.87% |
| 2020 Q3 | 190.23 Million CNY | 5.68% |
| 2019 Q1 | 124.44 Million CNY | 6.82% |
| 2019 Q3 | 137.37 Million CNY | -15.03% |
| 2019 FY | 1.06 Billion CNY | 122.78% |
| 2019 Q4 | 105.21 Million CNY | -23.41% |
| 2019 Q2 | 161.68 Million CNY | 29.92% |
| 2018 Q2 | 132.28 Million CNY | 17.68% |
| 2018 Q3 | 118.53 Million CNY | -10.4% |
| 2018 FY | 479.73 Million CNY | 4.08% |
| 2018 Q4 | 116.49 Million CNY | -1.72% |
| 2018 Q1 | 112.41 Million CNY | -30.99% |
| 2017 Q3 | 104.38 Million CNY | 15.8% |
| 2017 Q1 | 103.47 Million CNY | 4.28% |
| 2017 Q4 | 162.89 Million CNY | 56.05% |
| 2017 Q2 | 90.14 Million CNY | -12.89% |
| 2017 FY | 460.9 Million CNY | 32.88% |
| 2016 Q3 | 89.11 Million CNY | 16.58% |
| 2016 Q1 | 82.06 Million CNY | 154.77% |
| 2016 FY | 346.84 Million CNY | 33.92% |
| 2016 Q4 | 99.22 Million CNY | 11.35% |
| 2016 Q2 | 76.43 Million CNY | -6.86% |
| 2015 FY | 258.99 Million CNY | 43.5% |
| 2015 Q2 | 67.68 Million CNY | -13.56% |
| 2015 Q4 | 32.21 Million CNY | -60.13% |
| 2015 Q3 | 80.79 Million CNY | 19.38% |
| 2015 Q1 | 78.3 Million CNY | -13.4% |
| 2014 Q3 | 40.41 Million CNY | 31.6% |
| 2014 Q4 | 90.41 Million CNY | 123.73% |
| 2014 FY | 180.48 Million CNY | 67.9% |
| 2014 Q1 | 18.95 Million CNY | -37.89% |
| 2014 Q2 | 30.7 Million CNY | 62.04% |
| 2013 Q4 | 30.51 Million CNY | 5.98% |
| 2013 Q1 | 6.33 Million CNY | 106.77% |
| 2013 FY | 107.49 Million CNY | 368.19% |
| 2013 Q3 | 28.79 Million CNY | -31.21% |
| 2013 Q2 | 41.85 Million CNY | 560.21% |
| 2012 Q1 | -10.74 Million CNY | 94.81% |
| 2012 Q2 | -8.12 Million CNY | 24.33% |
| 2012 Q3 | 72.45 Million CNY | 991.53% |
| 2012 Q4 | -93.67 Million CNY | -229.28% |
| 2012 FY | -40.08 Million CNY | 75.29% |
| 2011 Q4 | -206.76 Million CNY | -1454.7% |
| 2011 Q2 | 14.24 Million CNY | -5.42% |
| 2011 Q1 | 15.05 Million CNY | 119.22% |
| 2011 FY | -162.2 Million CNY | -1276.77% |
| 2011 Q3 | 15.26 Million CNY | 7.17% |
| 2010 Q2 | 25.98 Million CNY | 20.2% |
| 2010 Q1 | 21.61 Million CNY | 407.54% |
| 2010 Q4 | -78.33 Million CNY | -513.23% |
| 2010 FY | -11.78 Million CNY | -119.82% |
| 2010 Q3 | 18.95 Million CNY | -27.04% |
| 2009 Q3 | 19.55 Million CNY | -30.88% |
| 2009 FY | 59.45 Million CNY | 14.73% |
| 2009 Q4 | -7.02 Million CNY | -135.94% |
| 2009 Q1 | 18.63 Million CNY | 261.44% |
| 2009 Q2 | 28.29 Million CNY | 51.82% |
| 2008 Q2 | 28.35 Million CNY | 54.88% |
| 2008 FY | 51.82 Million CNY | -46.21% |
| 2008 Q4 | -11.54 Million CNY | -169.07% |
| 2008 Q3 | 16.71 Million CNY | -41.05% |
| 2008 Q1 | 18.3 Million CNY | -26.61% |
| 2007 Q4 | 24.94 Million CNY | -3.81% |
| 2007 Q1 | 12.88 Million CNY | 243.09% |
| 2007 FY | 96.34 Million CNY | 413.17% |
| 2007 Q2 | 32.58 Million CNY | 152.84% |
| 2007 Q3 | 25.92 Million CNY | -20.42% |
| 2006 Q1 | 11.25 Million CNY | 288.7% |
| 2006 FY | 18.77 Million CNY | -36.51% |
| 2006 Q4 | -9 Million CNY | -220.31% |
| 2006 Q3 | 7.48 Million CNY | -17.17% |
| 2006 Q2 | 9.03 Million CNY | -19.71% |
| 2005 Q4 | 2.89 Million CNY | -76.15% |
| 2005 Q1 | 10.3 Million CNY | 171.99% |
| 2005 Q2 | 4.34 Million CNY | -57.79% |
| 2005 Q3 | 12.14 Million CNY | 179.25% |
| 2005 FY | 29.57 Million CNY | 75.49% |
| 2004 Q2 | 12.05 Million CNY | 0.19% |
| 2004 FY | 16.85 Million CNY | -65.31% |
| 2004 Q1 | 12.03 Million CNY | 2.08% |
| 2004 Q3 | 7.06 Million CNY | -41.42% |
| 2004 Q4 | -14.31 Million CNY | -302.57% |
| 2003 FY | 48.56 Million CNY | 2.47% |
| 2003 Q4 | 11.79 Million CNY | 38.16% |
| 2003 Q1 | 13.02 Million CNY | 31.72% |
| 2003 Q2 | 15.22 Million CNY | 16.92% |
| 2003 Q3 | 8.53 Million CNY | -43.94% |
| 2002 Q3 | 10.69 Million CNY | -14.51% |
| 2002 FY | 47.39 Million CNY | -15.22% |
| 2002 Q1 | 14.3 Million CNY | 0.0% |
| 2002 Q2 | 12.51 Million CNY | -12.5% |
| 2002 Q4 | 9.88 Million CNY | -7.6% |
| 2001 FY | 55.9 Million CNY | -17.42% |
| 2000 FY | 67.69 Million CNY | -25.54% |
| 1999 FY | 90.91 Million CNY | 24.23% |
| 1998 FY | 73.18 Million CNY | 60.43% |
| 1997 FY | 45.61 Million CNY | 41.58% |
| 1996 FY | 32.22 Million CNY | 20.58% |
| 1995 FY | 26.72 Million CNY | 25.7% |
| 1994 FY | 21.25 Million CNY | 84.04% |
| 1993 FY | 11.55 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 4.9 Billion CNY | 69.609% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.39 Billion CNY | 56.031% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 788.26 Million CNY | -89.299% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 82.83 Million CNY | -1701.293% |
| Aurora Optoelectronics Co.,Ltd. | -505.31 Million CNY | 395.298% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -37.56 Million CNY | 4071.783% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 114.81 Million CNY | -1199.662% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.36 Billion CNY | -9.31% |